REG - ABN Amro N.V. - Stabilisation Notice

ABN Amro Bank NVAnnouncement

30/01/2024 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240130:nRSd2512Ba&default-theme=true

RNS Number : 2512B  ABN Amro N.V.  30 January 2024

30 January 2024

Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful.

Argenta Spaarbank N.V.

Stabilisation Notice

ABN AMRO BANK NV (contact: Dominique Monnink telephone: +31- 20-3836967
hereby) hereby gives notice, as Coordinating Stabilisation Manager, that the
Stabilisation Manager(s) named below may stabilise the offer of the following
securities in accordance with Commission Delegated Regulation (EU) 2016/1052
of 8 March 2016 supplementing Regulation (EU) No 596/2014 and/or the UK FCA
Stabilisation Binding Technical Standards.

 The securities: 1  (#_ftn1)
 Issuer:                                                          Argenta Spaarbank N.V.
 Guarantor (if any):
 Aggregate nominal amount:                                        TBD
 Description:                                                     Senior unsecured notes due 2034
 Offer price:                                                     TBD
 Other offer terms: 2  (#_ftn2)                                   TBD
 Stabilisation:
 Stabilising Manager(s): 3  (#_ftn3)                              ABN AMRO Bank NV, LBBW, Natixis, Nord LB.

 Stabilisation period expected to start on: 4  (#_ftn4)           30 January 2024
 Stabilisation period expected to end no later than: 5  (#_ftn5)  29 February 2024 (30 days after the proposed issue date of the securities) 6 
                                                                  (#_ftn6)
 Maximum size of over-allotment facility: 7  (#_ftn7)             5% of the aggregate nominal amount stated above.

In connection with the offer of the above securities, the Stabilisation
Manager(s) may over-allot the securities or effect transactions with a view to
supporting the market price of the securities during the stabilisation period
at a level higher than that which might otherwise prevail. However,
stabilisation may not necessarily occur and any stabilisation action, if
begun, may cease at any time. Any stabilisation action or over-allotment shall
be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only
addressed to and directed at persons outside the United Kingdom and persons in
the United Kingdom who have professional experience in matters related to
investments or who are high net worth persons within Article 12(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and
must not be acted on or relied on by other persons in the United Kingdom.

 

If and to the extent that this announcement is communicated in, or the offer
of the securities to which it relates is made in, any EEA Member State before
the publication of a prospectus in relation to the securities which has been
approved by the competent authority in that Member State in accordance with
Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been
approved by a competent authority in another Member State and notified to the
competent authority in that Member State in accordance with the EEA Prospectus
Regulation), this announcement and the offer are only addressed to and
directed at persons in that Member State who are qualified investors within
the meaning of the EEA Prospectus Regulation (or who are other persons to whom
the offer may lawfully be addressed) and must not be acted on or relied on by
other persons in that Member State.

 

If and to the extent that this announcement is communicated in, or the offer
of the securities to which it relates is made in, the UK before the
publication of a prospectus in relation to the securities which has been
approved by the competent authority in the UK in accordance with Regulation
(EU) 2017/1129 as it forms part of domestic law by virtue of the European
Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this
announcement and the offer are only addressed to and directed at persons in
the UK who are qualified investors within the meaning of the UK Prospectus
Regulation (or who are other persons to whom the offer may lawfully be
addressed) and must not be acted on or relied on by other persons in the UK.

 

This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There will be no public offer of securities in the United
States.

END

 

 

 1  (#_ftnref1) Article 8(4) of the Regulation requires disclosure of the
terms of the offer (including the spread to the benchmark, if any, once it has
been fixed).

 2  (#_ftnref2) For example, in a convertible offering, include conversion
price. Delete if inapplicable.

 3  (#_ftnref3) Article 9(1)(d) requires disclosure of the identity of the
stabilisation managers.

 4  (#_ftnref4) Article 9(1)(c) requires disclosure of the beginning of the
stabilisation period.

 5  (#_ftnref5) Article 9(1)(c) requires disclosure of the end of the
stabilisation period.

 6  (#_ftnref6) Alternatively, if shorter, the stabilisation period must end
no later than 60 days after the date of the allotment.

 7  (#_ftnref7) Article 9(1)(e) requires disclosure of the existence and
maximum size of any overallotment facility. The disclosure should reflect the
terms of the underwriting/dealer agreement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STASEMFDUELSEDF